RSS   Newsletter   Contact   Advertise with us
Post Online Media

Elcelyx elects Sandy Mahatme to board of directors

ElcelyxElcelyx Therapeutics, a weight management company, announced that Sandesh Mahatme has been appointed to its board of directors as an independent director.
Article continues below

READ MORE Nature Group chairman Nigel Sandy resigns

Mr. Mahatme is currently senior vice president, chief financial officer at Sarepta Therapeutics.

Prior to joining Sarepta in 2012, Mr. Mahatme worked at Celgene Corporation, a biopharmaceutical company, where he served in various roles, including senior vice president of corporate development, senior vice president of finance, corporate treasurer and head of tax.

Prior to working at Celgene, he worked for Pfizer for eight and a half years in senior roles in business development and corporate tax.

Mr. Mahatme started his career at Ernst & Young where he advised multinational corporations on a broad range of transactions.

He holds Master of Laws (LL.M.) degrees from Cornell Law School and NYU School of Law and is a member of the New York State Bar Association. He is also a board member of Flexion Therapeutics and Aeglea Biotherapeutics.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy